Back
4D Molecular Therapeutics Stock Predictions
Sponsored
FDMT
Sponsored
My #1 Coin is...
All the details are on the next page.
Sell
50
FDMT
4D Molecular Therapeutics
Last Price:
26.24
Seasonality Move:
-18.33%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.4D Molecular Therapeutics Stock Forecast
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically risen by 5.5% based on the past 3 years of stock performance.
- 4D Molecular Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is 4D Molecular Therapeutics Stock Undervalued?
The current 4D Molecular Therapeutics [FDMT] share price is $26.33. The Score for FDMT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal. - FDMT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will 4D Molecular Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, 4D Molecular Therapeutics has on average historically risen by 5.5% based on the past 3 years of stock performance.
4D Molecular Therapeutics Stock Rating
Sell
50
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics overpriced?
- 4D Molecular Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
4D Molecular Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
4dmoleculartherapeutics.com
52-Week Data
52-Week High:
36.25
52-Week Low:
9.44
Prediction Charts
Market Cap:
1.31B
Price in USD:
26.33
Volume:
340.04K
Beta:
3.00
Technical Analysis
SMA50:
28.22
SMA100:
25.09
SMA200:
19.48
52-Wk Change:
59.38%
Stock Predictions
-
Is 4D Molecular Therapeutics stock public?
Yes, 4D Molecular Therapeutics is a publicly traded company. -
What is the 4D Molecular Therapeutics stock quote today?
The 4D Molecular Therapeutics stock price is 26.33 USD today. -
How to buy 4D Molecular Therapeutics stock online?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Apr-19 | 24.61 | 25.28 | 25.56 | 24.38 |
Apr-22 | 25.60 | 26.43 | 26.92 | 24.57 |
Apr-23 | 26.45 | 24.81 | 26.89 | 24.69 |
Apr-24 | 25.19 | 24.25 | 25.38 | 24.23 |
Apr-25 | 23.51 | 23.53 | 23.98 | 22.91 |
Apr-26 | 23.45 | 23.25 | 23.86 | 22.75 |
Apr-29 | 23.58 | 24.25 | 24.66 | 23.34 |
Apr-30 | 23.76 | 23.93 | 24.56 | 23.57 |
May-1 | 24.00 | 25.35 | 26.59 | 24.00 |
May-2 | 25.31 | 26.37 | 26.54 | 24.93 |
May-3 | 27.21 | 26.38 | 27.84 | 26.17 |
May-6 | 26.47 | 26.74 | 27.00 | 26.41 |
May-7 | 26.79 | 26.79 | 27.09 | 26.26 |
May-8 | 26.26 | 26.33 | 26.78 | 25.88 |
4D Molecular Therapeutics Earnings
4D Molecular Therapeutics Earnings Report: Per Share 4D Molecular Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
4D Molecular Therapeutics Forecast Revenue Growth
4D Molecular Therapeutics Stock Analysis: Historical quarterly revenues per share for 4D Molecular Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.38 per share, and a decrease next year of $0.32 per share.
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.